FY2024 EPS Estimates for Molina Healthcare, Inc. Lowered by Zacks Research (NYSE:MOH)

Molina Healthcare, Inc. (NYSE:MOH - Free Report) - Equities research analysts at Zacks Research dropped their FY2024 earnings estimates for Molina Healthcare in a report issued on Tuesday, May 14th. Zacks Research analyst D. Chatterjee now anticipates that the company will earn $23.53 per share for the year, down from their prior estimate of $23.58. The consensus estimate for Molina Healthcare's current full-year earnings is $23.59 per share. Zacks Research also issued estimates for Molina Healthcare's Q2 2025 earnings at $6.89 EPS, Q3 2025 earnings at $6.74 EPS, FY2025 earnings at $27.05 EPS, Q1 2026 earnings at $7.00 EPS and FY2026 earnings at $31.10 EPS.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, topping analysts' consensus estimates of $5.46 by $0.27. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The company had revenue of $9.93 billion for the quarter, compared to analysts' expectations of $9.45 billion. During the same period last year, the firm earned $5.81 EPS. Molina Healthcare's revenue for the quarter was up 21.9% compared to the same quarter last year.

Other analysts have also recently issued reports about the stock. Bank of America cut shares of Molina Healthcare from a "neutral" rating to an "underperform" rating and set a $439.00 price objective for the company. in a research note on Thursday, March 28th. StockNews.com downgraded Molina Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Thursday, February 8th. Cantor Fitzgerald reiterated an "overweight" rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, April 4th. Wells Fargo & Company lowered their price target on Molina Healthcare from $410.00 to $375.00 and set an "equal weight" rating on the stock in a report on Monday, April 29th. Finally, Stephens restated an "equal weight" rating and issued a $390.00 price target on shares of Molina Healthcare in a research note on Thursday, April 25th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $404.90.

Molina Healthcare Stock Performance

NYSE MOH traded down $4.13 on Wednesday, reaching $345.84. 371,943 shares of the stock were exchanged, compared to its average volume of 398,274. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. Molina Healthcare has a one year low of $266.35 and a one year high of $423.92. The firm has a market capitalization of $20.27 billion, a PE ratio of 18.77, a PEG ratio of 1.08 and a beta of 0.54. The company's 50-day simple moving average is $377.04 and its two-hundred day simple moving average is $372.18.

Institutional Investors Weigh In On Molina Healthcare

Several large investors have recently added to or reduced their stakes in MOH. Raymond James Financial Services Advisors Inc. raised its stake in shares of Molina Healthcare by 59.4% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 1,908 shares of the company's stock valued at $626,000 after acquiring an additional 711 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its stake in Molina Healthcare by 4.5% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,289 shares of the company's stock worth $4,029,000 after purchasing an additional 531 shares during the last quarter. Park Avenue Securities LLC purchased a new position in shares of Molina Healthcare during the third quarter valued at approximately $545,000. Assetmark Inc. grew its stake in shares of Molina Healthcare by 17.7% during the third quarter. Assetmark Inc. now owns 3,018 shares of the company's stock valued at $990,000 after buying an additional 453 shares during the last quarter. Finally, Fifth Third Bancorp raised its holdings in shares of Molina Healthcare by 26.9% in the third quarter. Fifth Third Bancorp now owns 1,787 shares of the company's stock worth $586,000 after buying an additional 379 shares during the period. 98.50% of the stock is owned by institutional investors.

Insider Activity

In related news, Director Richard M. Schapiro sold 1,000 shares of the business's stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total value of $401,050.00. Following the sale, the director now owns 11,207 shares in the company, valued at $4,494,567.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.11% of the company's stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.